抗骨质疏松治疗在糖尿病患者中的作用
Harsh Durgia1, Rajan Palui2, Jayaprakash Sahoo3
1Dr. Harsh's Endocrine and Diabetes Center, Rajkot, Gujarat, India.
Indian journal of endocrinology and metabolism
|April 4, 2025
概括
由于骨折风险增加,糖尿病 (DM) 中的骨质疏松症治疗至关重要. 合成代谢剂,特别是特里巴化物,对糖尿病患者的低骨周转率有希望,但需要更多的研究.
科学领域:
- 内分泌学 在内分泌学.
- 代谢障碍 代谢障碍 代谢障碍
- 骨生物学 骨生物学 骨生物学
背景情况:
- 糖尿病是一种代谢障碍,影响骨健康,增加骨折风险和死亡率.
- 骨质疏松症 (OP) 在DM中提出了独特的挑战,通常以低骨周转率为特征,不同于绝经后的OP.
- 有效的OP管理对于糖尿病患者来说至关重要,以减轻骨折并发症.
研究的目的:
- 审查当前对糖尿病中骨质疏松症的理解.
- 评估用于治疗糖尿病骨质炎的合成代谢剂的疗效和安全性.
- 为了识别有关DM患者的骨质合成药治疗的文献上的差距.
主要方法:
- 文献综述侧重于糖尿病中骨质疏松症的病变发生.
- 对糖尿病骨病中的合成代谢剂和抗吸收剂研究的分析.
- 在DM群体中检查特里巴拉提德,阿巴洛巴拉提德和罗莫祖马布的证据.
主要成果:
- 骨质疏松症在DM中是一种低骨循环的疾病,这表明合成代谢剂可能是有益的.
- 特里巴拉提德在患有OP的糖尿病患者中显示出最多的疗效和安全性证据.
- 在这个人群中,对于其他类固醇药物,如阿巴洛帕拉提德和罗莫祖马布,存在有限的数据.
结论:
- 合成代谢剂对治疗糖尿病骨质疏松症有希望.
- 特里巴拉提德是一种可行的选择,但对其他药物需要进一步研究.
- 针对1型和2型DM群体的具体研究对于指导未来治疗策略至关重要.
关键词:
阿巴洛帕拉蒂德 (Abaloparatide) 是一种类型.一种类型的 anabolic 类型的 anabolic.在糖尿病中,糖尿病是血糖性糖尿病.骨质疏松症是一种骨质疏松症.罗莫索祖马布 (romosozumab) 是一种药物.皮制剂是一种皮制剂.更多相关视频
相关概念视频
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
143
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
143
01:15Diabetes: Management and Pharmacotherapy
214
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
214
01:29Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
01:16Insulin: Dosing Regimen and Adverse Effects
129
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
129
01:25Role of Vitamins in Maintaining Bone Health
3.1K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.1K
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
128
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
128